US Government Asks About Eli Lilly Company in China
US Government Asks About Eli Lilly Company in China
美國政府詢問禮來公司在中國的情況
Introduction
A group of US leaders is checking the work of a medicine company called Eli Lilly in China.
一群美國領導人正在調查一家名為禮來（Eli Lilly）的製藥公司在中國的運作。
Main Body
Eli Lilly did many medical tests in China. Some tests were with the Chinese army. Some tests were in a place called Xinjiang. US leaders worry that China took secret medicine information from the company. This could be bad for US safety.
禮來在中國進行了許多醫療測試。部分測試是與中國軍隊合作的。有些測試則是在一個叫新疆的地方進行。美國領導人擔心中國從該公司獲取了秘密藥物資訊，這可能會對美國的安全造成不利影響。
Leaders also worry about the people in the tests. Some reports say people in Xinjiang are not free. The leaders want to know if the people in the tests said 'yes' freely. They want to know if the tests were fair.
領導人也擔心測試參與者的情況。部分報告指出新疆的人民並不自由。領導人想知道測試參與者是否在自由意願下表示「同意」，以及測試過程是否公平。
Eli Lilly is spending a lot of money in China. They are building new factories. They are working with Chinese companies. The US government wants to know if this is safe.
禮來在中國投入了大量資金。他們正在建設新工廠，並與中國公司合作。美國政府想知道這樣做是否安全。
Conclusion
Eli Lilly knows about the questions. They must give answers by July 17.
禮來已獲知這些問題，他們必須在 7 月 17 日前提供答案。
Vocabulary Learning
The 'Doing' Words (Present Continuous)
Look at how the text describes things happening right now:
- spending (spending money)
- building (building factories)
- working (working with companies)
The Simple Pattern:
Am/Is/Are + Verb + ing Something is in progress.
Examples from the story:
- Eli Lilly is spending money. (They are doing it now/these days).
- They are building factories. (The work is not finished yet).
Useful 'Who' & 'What' Words
To reach A2, you need to group people and things. Here is the logic from the text:
| Group | Word used |
|---|---|
| Power | Leaders / Government |
| Business | Company / Factories |
| Health | Medicine / Tests |
Quick Tip: Use "Government" for the people who make the laws and "Company" for the people who make the money.
Vocabulary Learning
U.S. Congressional Investigation into Eli Lilly's Clinical Research in China
美國國會調查禮來公司在中國的臨床研究
Introduction
The House Select Committee on the Chinese Communist Party has started a formal investigation into the clinical trial activities of the pharmaceutical company Eli Lilly in China.
美國眾議院中國共產黨特設委員會已開始正式調查製藥公司禮來（Eli Lilly）在中國的臨床試驗活動。
Main Body
The investigation, led by Chairman John Moolenaar, focuses on the possible links between private medical research and Chinese state security. Specifically, the Committee has asked for documents regarding clinical trials conducted in the Xinjiang region and at facilities connected to the People's Liberation Army (PLA). According to public records, Eli Lilly has worked on more than 220 studies in China since 2003, including 16 with military medical centers. The Committee emphasized that these partnerships might allow the Chinese military to gain unauthorized access to American biotechnology and intellectual property, which could harm U.S. national security.
此次調查由主席 John Moolenaar 領導，重點關注私人醫療研究與中國國家安全之間可能的聯繫。具體而言，委員會要求提供關於在新疆地區以及與中國人民解放軍（PLA）相關設施進行的臨床試驗文件。根據公開記錄，禮來公司自 2003 年起在中國進行了 220 多項研究，其中包括 16 項與軍方醫療中心合作的研究。委員會強調，這些合作可能會讓中國軍方獲得美國生物技術與知識產權的未經授權訪問權，進而損害美國國家安全。
Furthermore, the investigation examines ethical issues regarding whether participants in these trials gave their voluntary consent. The Committee mentioned reports from the United Nations and the U.S. State Department about human rights abuses in Xinjiang, suggesting that people in that region may not be able to participate in medical trials freely. Additionally, lawmakers are questioning if China's rapid growth in clinical research has led to lower ethical standards. These concerns come as Eli Lilly increases its investment in the region, including a $3 billion expansion of its manufacturing and several large partnerships with Chinese pharmaceutical companies.
此外，此次調查還檢視了關於試驗參與者是否自願同意參加的倫理問題。委員會提到聯合國與美國國務院關於新疆人權侵害的報告，暗示該地區的人民可能無法自由參與醫療試驗。此外，立法者質疑中國臨床研究的快速成長是否導致倫理標準下降。這些憂慮正值禮來公司增加在該地區的投資之際，包括 30 億美元的生產擴展以及與數家中國製藥公司的重大合作。
Conclusion
Eli Lilly has confirmed that it received the inquiry and is currently reviewing the request for documents, which must be submitted by July 17.
禮來公司已確認收到詢問，目前正在審查提交文件的要求，文件必須在 7 月 17 日前提交。
Vocabulary Learning
🚀 The 'Power Shift': Moving from Simple to Sophisticated Verbs
At the A2 level, you likely use basic verbs like start, ask, say, or do. To reach B2, you need to use 'precise verbs' that describe how or why something is happening. This changes your English from a basic description to a professional analysis.
🔍 The Upgrade Path
Look at how the article transforms basic ideas into high-level academic English:
| A2 Basic Thought | B2 Professional Upgrade | Context from Text |
|---|---|---|
| Started an investigation | Launched / Initiated | "...has started a formal investigation" |
| Asked for papers | Requested documents | "...the Committee has asked for documents" |
| Gives a reason | Emphasized / Suggested | "The Committee emphasized..." |
| Check the papers | Reviewing the request | "...is currently reviewing the request" |
💡 Why this matters for your fluency
B2 speakers don't just use a bigger dictionary; they use verbs that show intent.
- Example: If you say "I asked my boss for a holiday," it's correct (A2).
- B2 Version: "I requested a leave of absence from my manager."
The second version sounds more authoritative and formal, which is exactly what you need for university or business environments.
🛠️ Quick Application: The 'Nuance' Trick
Notice the word "suggesting" in the text. It doesn't say "proving."
- A2: "The report says people are not free." (Too direct/simple)
- B2: "The report is suggesting that people may not be free." (More cautious and professional)
Pro Tip: When you want to reach B2, stop using 'say' and 'think'. Instead, try: claim, suggest, emphasize, or confirm.
Vocabulary Learning
Congressional Inquiry into Eli Lilly's Clinical Research Operations within the People's Republic of China
美國國會就禮來製藥在中國的臨床研究營運進行調查
Introduction
The House Select Committee on the Chinese Communist Party has initiated a formal investigation into the clinical trial activities of Eli Lilly and Company in China.
美國眾議院中國共產黨特設委員會已正式對禮來製藥（Eli Lilly and Company）在中國的臨床試驗活動展開調查。
Main Body
The inquiry, led by Chairman John Moolenaar, focuses on the potential intersection of private pharmaceutical research and Chinese state security interests. Specifically, the Committee has requested documentation regarding clinical trials conducted at facilities affiliated with the People's Liberation Army (PLA) and within the Xinjiang region. Public records indicate that since 2003, Eli Lilly has collaborated on over 220 studies in China, including 16 involving military medical centers and 11 in Xinjiang. The Committee posits that such collaborations may facilitate the unauthorized transfer of proprietary biotechnology and intellectual property to the Chinese military, thereby compromising U.S. national security and economic competitiveness.
此次調查由主席 John Moolenaar 領導，重點關注私人製藥研究與中國國家安全利益之間潛在的交集。具體而言，委員會已要求提供關於在中國人民解放軍（PLA）附屬機構以及新疆地區進行的臨床試驗文件。公開記錄顯示，自 2003 年起，禮來製藥在中國合作了超過 220 項研究，其中包括 16 項涉及軍方醫療中心以及 11 項在新疆進行。委員會認為，此類合作可能會促使專有生物技術與知識產權在未經授權的情況下轉移至中國軍方，從而損害美國的國家安全與經濟競爭力。
Furthermore, the investigation addresses ethical concerns regarding participant autonomy and informed consent. The Committee cites reports from the United Nations and the U.S. State Department alleging systemic human rights abuses in Xinjiang, suggesting that the environment may preclude the possibility of voluntary participation in medical trials. Additionally, the inquiry examines whether the rapid expansion of China's clinical trial infrastructure—driven by state subsidies and regulatory shifts—has compromised ethical standards. These concerns coincide with Eli Lilly's increased capital commitment to the region, including a $3 billion manufacturing expansion and multi-billion dollar research partnerships with Innovent Biologics and Haisco Pharmaceutical Group.
此外，調查還涉及參與者自主權與知情同意的倫理疑慮。委員會引用聯合國與美國國務院的報告，指控新疆存在系統性人權侵害，暗示該環境可能排除醫療試驗自願參與的可能性。此外，調查還在研究中國在國家補貼與監管轉型驅動下，臨床試驗基礎設施的快速擴張是否損害了倫理標準。這些憂慮與禮來製藥增加對該地區的資本投入相吻合，包括 30 億美元的製造擴張，以及與信達生物（Innovent Biologics）和海思可藥業（Haisco Pharmaceutical Group）價值數十億美元的研究合作夥伴關係。
Conclusion
Eli Lilly has acknowledged receipt of the inquiry and is currently reviewing the request for documentation, which is due by July 17.
禮來製藥已確認收到調查要求，目前正在審閱相關文件請求，該文件需於 7 月 17 日前提交。
Vocabulary Learning
The Architecture of Formal Speculation
To move from B2 to C2, a student must transition from stating facts to constructing nuanced hypotheses. The provided text is a masterclass in Hedging and Epistemic Modality—the art of suggesting a possibility without claiming absolute certainty, which is essential for high-level diplomatic, legal, and academic writing.
◈ The 'Nuance Pivot': From Certainty to Possibility
Notice the shift from the concrete (the existence of trials) to the speculative (the risk of espionage). The author avoids saying "The trials leaked data," which would be a legal liability. Instead, they use:
*"...collaborations may facilitate the unauthorized transfer..."
C2 Linguistic Breakdown:
- May facilitate: This isn't just a modal of possibility; it is a strategic buffer. It frames the risk as a logical consequence rather than a proven event.
- Preclude the possibility of: Instead of saying "participants cannot consent," the text uses a double-negative structure (preclude + possibility). This creates a formal distance, suggesting that the environment makes the action impossible, rather than claiming a specific instance of coercion.
◈ Lexical Precision: High-Density Nominals
C2 English is characterized by 'nominalization'—turning complex processes into single noun phrases to increase information density. Compare these two levels:
- B2 Approach: China is spending a lot of money to make clinical trials grow faster, and this might make ethical standards lower.
- C2 Approach (The Text): *"...the rapid expansion of China's clinical trial infrastructure—driven by state subsidies and regulatory shifts—has compromised ethical standards."
Analysis of the 'C2' upgrade:
- "Rapid expansion of... infrastructure": Replaces the verb "grow" with a conceptual noun phrase.
- "Driven by state subsidies": An appositive phrase that provides causality without needing a new sentence.
- "Regulatory shifts": A precise term for changes in law, replacing the vague "changes in rules."
◈ Sophisticated Collocations for the C2 Portfolio
Integrate these pairings into your writing to signal mastery:
- : (Specific ownership of scientific secrets)
- : (Indicating the problem is built into the system, not accidental)
- : (A formal way to describe financial investment)
- : (Establishing the official nature of the process)